Core Viewpoint - Jiahe Meikang (Beijing) Technology Co., Ltd. has faced disciplinary action from the Shanghai Stock Exchange due to accounting errors in its financial reports for 2022 and 2023, leading to significant adjustments in reported profits and net income [2][3] Financial Reporting Issues - The company disclosed multiple announcements on April 30, 2025, correcting accounting errors related to cost recognition and insufficient inventory impairment provisions for 2022 and 2023 [2] - For 2022, total profit was reduced by 4.0544 million yuan, representing a 14.81% decrease, while net profit was adjusted down by 3.4463 million yuan, a decrease of 8.46% [2] - For 2023, total profit was reduced by 11.3478 million yuan, a 169.95% increase in losses, and net profit was adjusted down by 10.213 million yuan, a decrease of 50.35% [2] Disciplinary Actions - The Shanghai Stock Exchange criticized the company and its key executives for failing to ensure accurate financial disclosures, impacting investors' rights [3] - The disciplinary committee found that the company's prior accounting errors were significant and warranted criticism, despite the company's claims of corrective measures [3] Company Performance and Market Position - Jiahe Meikang is a leading provider of medical information technology products and services, holding a 15.0% market share in the electronic medical record system market as of 2024, marking its 11th consecutive year at the top [4] - However, the company has experienced declining revenues, with figures of 717 million yuan in 2022, 695 million yuan in 2023, and a projected 330 million yuan in 2024, reflecting year-on-year changes of -9.97%, -3.04%, -14.85%, and -30.67% respectively [4] - Net profits have also declined significantly, with losses reported at 25.6 million yuan in 2023 and 17.4 million yuan in the first three quarters of 2025 [4] Industry Challenges - The company cited a complex industry environment, with delayed demand from hospital clients, prolonged bidding processes, and increased project implementation costs as factors contributing to revenue decline and losses [5]
会计差错致两年调减净利润超千万,嘉和美康被通报批评